UCP2 Reduces Insulin Secretion by Lowering Mitochondrial ROS
Author Information
Author(s): Charles Affourtit, Martin Jastroch, Martin D. Brand
Primary Institution: Mitochondrial Biology Unit, Medical Research Council, Cambridge, UK
Hypothesis
UCP2 regulates glucose-stimulated insulin secretion (GSIS) by modulating mitochondrial reactive oxygen species (ROS) levels.
Conclusion
UCP2 plays a dual role in pancreatic β cells by reducing GSIS and preventing oxidative stress.
Supporting Evidence
- UCP2 knockdown in INS-1E cells leads to improved GSIS.
- UCP2 activity lowers mitochondrial ROS at high glucose levels.
- MnTMPyP, an antioxidant, abolishes the GSIS improvement seen with UCP2 knockdown.
- UCP2 knockdown increases mitochondrial coupling efficiency.
- UCP2 knockdown lowers mitochondrial respiratory activity.
Takeaway
UCP2 is a protein in pancreatic cells that helps control insulin release. When it is reduced, insulin release increases, but this effect goes away if you use an antioxidant.
Methodology
The study used INS-1E insulinoma cells to assess the effects of UCP2 knockdown on GSIS and mitochondrial bioenergetics.
Potential Biases
Potential confounding effects from genetic background in mouse models of UCP2 knockout.
Limitations
The findings are based on a clonal β-cell model, which may not fully represent physiological conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website